General Information of Drug Transporter (DT)
DT ID DTD0384 Transporter Info
Gene Name SLC4A3
Transporter Name Anion exchange protein 3
Gene ID
6508
UniProt ID
P48751

Transcriptional Regulation of This DT (TSR)

TF Superclass1: Basic domains

      Class1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in breast cancer condition [1]

TF Protein Name

Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Aryl hydrocarbon receptor (AHR) has been reported to activate the transcription of SLC4A3 gene in breast cancer condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

        ARNT 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in breast cancer condition [1]

TF Protein Name

Aryl hydrocarbon receptor nuclear translocator Transcription Factor Info

Affected Drug/Substrate

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLC4A3 gene in breast cancer condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

        MYC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC4A3 gene in medulloblastoma condition [2]

TF Protein Name

Myc proto-oncogene protein Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Down regulating

Detailed Description

Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC4A3 gene in medulloblastoma condition, which leads to a decreased expression of the drug transporter Anion exchange protein 3.

        TCF4 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in colorectal cancer condition [3]

TF Protein Name

Transcription factor 4 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Transcription factor 4 (TCF4) has been reported to activate the transcription of SLC4A3 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

       Transcriptional Phenomenon2

Binding to SLC4A3 gene in glioblastoma multiforme condition [4]

TF Protein Name

Transcription factor 4 Transcription Factor Info

Affected Drug/Substrate

Temozolomide

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC4A3 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

      Class1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TFAP2C 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [5]

TF Protein Name

Transcription factor AP-2 gamma Transcription Factor Info

Tissue

Breast; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

TF Superclass2: Zinc-coordinating DNA-binding domains

      Class2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        AR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in prostate cancer condition [6]

TF Protein Name

Androgen receptor Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Androgen receptor (AR) has been reported to activate the transcription of SLC4A3 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

        HNF4A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC4A3 gene in health condition [7]

TF Protein Name

Hepatocyte nuclear factor 4-alpha Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC4A3 gene in health condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

        NR2F2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [5]

TF Protein Name

COUP transcription factor 2 Transcription Factor Info

Tissue

Bone marrow; Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

COUP transcription factor 2 (NR2F2) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        PPARD 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Repression of SLC4A3 gene in metabolic disorders condition [8]

TF Protein Name

Peroxisome proliferator-activated receptor delta Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Down regulating

Detailed Description

Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC4A3 gene in metabolic disorders condition, which leads to a decreased expression of the drug transporter Anion exchange protein 3.

      Class2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 7 TF(s) Regulating This DT

        CTCF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [5]

TF Protein Name

Transcriptional repressor CTCF Transcription Factor Info

Tissue

Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional repressor CTCF (CTCF) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        KLF9 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [9]

TF Protein Name

Krueppel-like factor 9 Transcription Factor Info

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Krueppel-like factor 9 (KLF9) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [10]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Blood; Bone marrow; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        WT1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in podocyte condition [11]

TF Protein Name

Wilms tumor protein Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Wilms tumor protein (WT1) has been reported to activate the transcription of SLC4A3 gene in podocyte condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

        ZBTB7A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [12]

TF Protein Name

Zinc finger and BTB domain-containing protein 7A Transcription Factor Info

Tissue

Bone marrow; Liver; Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        ZNF217 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC4A3 gene in breast cancer condition [13]

TF Protein Name

Zinc finger protein 217 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC4A3 gene in breast cancer condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

        ZNF263 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [10]

TF Protein Name

Zinc finger protein 263 Transcription Factor Info

Tissue

Kidney

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Zinc finger protein 263 (ZNF263) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

TF Superclass3: Helix-turn-helix domains

      Class3.1: Homeo domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        PBX1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [10]

TF Protein Name

Pre-B-cell leukemia transcription factor 1 Transcription Factor Info

Tissue

Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Pre-B-cell leukemia transcription factor 1 (PBX1) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

      Class3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        E2F6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [12]

TF Protein Name

Transcription factor E2F6 Transcription Factor Info

Tissue

Embryo

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2F6 (E2F6) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        FOXA2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [9]

TF Protein Name

Hepatocyte nuclear factor 3-beta Transcription Factor Info

Tissue

Embryo; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

      Class3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        SPI1 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC4A3 gene in acute promyelocytic leukemia (APL) condition [14]

TF Protein Name

Transcription factor PU.1 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC4A3 gene in acute promyelocytic leukemia (APL) condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

       Transcriptional Phenomenon2

Direct binding to SLC4A3 gene [12]

TF Protein Name

Transcription factor PU.1 Transcription Factor Info

Tissue

Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Umbilical cord blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor PU.1 (SPI1) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

        SPIB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [9]

TF Protein Name

Transcription factor Spi-B Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor Spi-B (SPIB) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

      Class3.7: ARID domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        KDM5B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [5]

TF Protein Name

Lysine-specific demethylase 5B Transcription Factor Info

Tissue

Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

TF Superclass5: alpha-Helices exposed by beta-structures

      Class5.1: MADS box factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        SRF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [9]

TF Protein Name

Serum response factor Transcription Factor Info

Tissue

Bone marrow; Embryo; Liver; Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Serum response factor (SRF) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.

TF Superclass6: Immunoglobulin fold

      Class6.3: p53 domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TP63 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Binding to SLC4A3 gene in epithelial to mesenchymal transition condition [15]

TF Protein Name

Tumor protein 63 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC4A3 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

       Transcriptional Phenomenon2

Binding to SLC4A3 gene in health condition [16]

TF Protein Name

Tumor protein 63 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Direct regulating

Detailed Description

Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC4A3 gene in health condition, which leads to an affected expression of the drug transporter Anion exchange protein 3.

      Class6.4: Runt domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        RUNX2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Activation of SLC4A3 gene in prostate cancer condition [17]

TF Protein Name

Runt-related transcription factor 2 Transcription Factor Info

Studied Phenotype

.

Related DT Changes

Up regulating

Detailed Description

Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC4A3 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Anion exchange protein 3.

TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold

      Class7.1: SMAD/NF-1 DNA-binding domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NFIC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon1

Direct binding to SLC4A3 gene [10]

TF Protein Name

Nuclear factor 1 C-type Transcription Factor Info

Tissue

Uterus

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Nuclear factor 1 C-type (NFIC) can directly bind to the SLC4A3 gene, which in turn affects the expression or function of the drug transporter Anion exchange protein 3.
References
1 High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicol Sci. 2012 Dec;130(2):349-61.
2 Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Cancer Res. 2010;70(20):8199-210.
3 Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol. 2008;28(8):2732-44.
4 Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol. 2013;15(3):279-89.
5 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
6 Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol Endocrinol. 2014;28(12):2012-24.
7 Molecular interactions between HNF4a, FOXA2 and GABP identified at regulatory DNA elements through ChIP-sequencing. Nucleic Acids Res. 2009;37(22):7498-508.
8 Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor. PLoS One. 2011;6(1):e16344.
9 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-226. (ID:ENSG00000114923)
10 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
11 Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. Kidney Int. 2015;88(2):321-31.
12 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
13 Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha. BMC Genomics. 2014;15(1):520.
14 Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia. J Hematol Oncol. 2013;6:25.
15 p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS One. 2013;8(5):e62547.
16 Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation. Nucleic Acids Res. 2012;40(15):7190-206.
17 Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Res. 2012;40(8):3538-47.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.